Map Explore Ask

More ▾

Track recordWhat has been tried, and how it went Read with AIAsk one trial or paper, answered in its own words CompareTwo to ten studies side by side MatchLabs that should be talking DigestWhat is new today FundingWhere the money is, and is not

Search/

Sources: ClinicalTrials.gov · Europe PMC · NIH RePORTER · OpenAlexContracts 0.3.3Research and education only, not treatment advice

what is known about paper:doi:10.18632/oncotarget.4216

Question

Understood asRecord DOI 10.18632/oncotarget.4216View getStudy → table

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial DOI 10.18632/oncotarget.4216 ↗

Computed from the knowledge API (getStudy); every record links to its source.

Read it with AI